| Proteus mirabilis (NORTHEAST Data) | |||||||
| 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | |
| penicillin | 0% n=85  | ||||||
| amoxicillin | 82.2% n=180  | 86% n=207  | 75.8% n=149  | ||||
| amoxicillin/clavulanate | 98.1% n=159  | 97.9% n=286  | 95.2% n=399  | 96.1% n=332  | 100% n=90  | ||
| ampicillin | 84.7% n=2794  | 80.4% n=2709  | 75.5% n=2856  | 79% n=2932  | 81.5% n=3029  | 75.4% n=1431  | |
| ampicillin/sulbactam | 89.3% n=1831  | 87.7% n=2176  | 88% n=1996  | 90.8% n=2236  | 93.2% n=2054  | 89.8% n=745  | |
| cefazolin | 89.7% n=2794  | 88.8% n=2994  | 85.2% n=2945  | 88.2% n=3019  | 90.7% n=2990  | 88.1% n=1431  | |
| cefotetan | 99.2% n=767  | 99.7% n=1743  | 99.3% n=1217  | 99.6% n=832  | 100% n=1096  | 100% n=138  | |
| cefoxitin | 89.5% n=76  | ||||||
| cefuroxime | 91.3% n=828  | 92% n=412  | 97% n=778  | 95.5% n=530  | 95.6% n=318  | ||
| cefotaxime | 99.6% n=251  | 99.6% n=244  | 100% n=147  | 100% n=114  | 100% n=102  | ||
| ceftazidime | 99.2% n=1431  | 99.2% n=1975  | 97.1% n=2073  | 96.8% n=1704  | 96.7% n=1643  | 92.9% n=326  | |
| ceftriaxone | 99.1% n=2165  | 94.5% n=2962  | 96.2% n=2863  | 96.6% n=2653  | 96.9% n=3002  | 93.2% n=1431  | |
| cefepime | 98.7% n=1451  | 99.3% n=1517  | 96.9% n=1646  | 96.5% n=1964  | 96.3% n=2146  | 92.9% n=1431  | |
| ciprofloxacin | 71.5% n=2649  | 64.4% n=2676  | 62.1% n=2614  | 64.5% n=2164  | 63.5% n=2479  | 58.3% n=967  | |
| levofloxacin | 72.6% n=1625  | 73% n=2122  | 62.9% n=1906  | 68.8% n=2205  | 66% n=2372  | 62.9% n=1147  | |
| gatifloxacin | 81.2% n=324  | ||||||
| moxifloxacin | 58% n=200  | 67.6% n=210  | |||||
| TMP/SMX | 86.9% n=2016  | 83.2% n=2534  | 77.1% n=2847  | 75.7% n=3016  | 77.8% n=3029  | 70.8% n=1431  | |
| gentamicin | 93.5% n=2722  | 90.6% n=2995  | 90.1% n=2863  | 89.6% n=3020  | 91.5% n=2994  | 89.8% n=1431  | |
| tobramycin | 94.7% n=2379  | 94.3% n=1954  | 92.2% n=1977  | 91.8% n=1411  | 92.3% n=982  | 98.3% n=240  | |
| amikacin | 99.7% n=1579  | 99.8% n=1793  | 99.5% n=2507  | 99.7% n=2318  | 99.6% n=2440  | 88.7% n=838  | |
| aztreonam | 93.9% n=1258  | 97.9% n=1442  | 95.6% n=1450  | 95.7% n=1252  | 96.2% n=1553  | 91.2% n=748  | |
| meropenem | 76.4% n=55  | 71.7% n=244  | 100% n=185  | 100% n=154  | 100% n=326  | ||
| imipenem | 97.7% n=1582  | 93.5% n=2054  | 86.1% n=2121  | 95.5% n=1598  | 97.9% n=891  | 33.6% n=384  | |
| piperacillin | 94.2% n=605  | 96.9% n=575  | 100% n=11  | 61.7% n=154  | |||
| pip/taz | 98.3% n=2348  | 99% n=2562  | 97% n=2919  | 99.6% n=2624  | 99.3% n=2652  | 98.8% n=1072  | |
| ticarcillin/clavulanate | 100% n=68  | 98.6% n=71  | 98.5% n=530  | 99.8% n=613  | 95% n=242  | ||
| Totals | 90.7% n=33737  | 89.4% n=38571  | 87% n=39294  | 88.4% n=36513  | 88.8% n=36346  | 83.1% n=15683  | |
This data is accurate as of: 11/22/2016 11:53:40 AM
Drugs with less than 10 isolates are removed from the chart and from the graph. The following drugs had some data removed: meropenem, ticarcillin/clavulanate, penicillin, piperacillin, amoxicillin/clavulanate, cefoxitin.




